Prevalence of axial spondyloarthritis in Poland.


Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 19 09 2019
accepted: 19 11 2019
pubmed: 6 12 2019
medline: 10 2 2021
entrez: 6 12 2019
Statut: ppublish

Résumé

The prevalence of axial spondyloarthritis (axSpA) in the published data varies significantly. Two types of axSpA can be distinguished depending upon the presence of abnormalities consistent with sacroiliitis on plain radiography: ankylosing spondylitis (AS) and nonradiographic axial SpA (nr-axSpA). The aim of this study is to perform a retrospective analysis of axSpA prevalence in Poland in the years 2008-2017. The National Health Fund (NHF) database for the period 2008-2017 was analysed. Data of all patients with the ICD-10 codes M46 (M46.1, M46.8, M46.9) or M45 (further named other inflammatory spondylopathies-OIS and AS, respectively) as the main or co-existing diagnosis were extracted and analysed. The AS prevalence was stable during the period under examination amounting to approximately 0.083%, while the OIS prevalence increased from 0.036 to 0.059%. For both men and women, the AS prevalence increased with age, reaching a maximum around the age of 70; however, in men, a marked increase in prevalence was observed earlier as compared to women (20-24 vs. 40-44 years, respectively). The OIS prevalence also increased with age; however, the maximum was reached earlier as in case of AS. Moreover, a sharp increase in OIS prevalence occurred earlier than in AS (15-19 years) with no difference between sexes. In Poland, approximately 0.1% of the population suffers from AS-the prevalence remained stable over the last decade. The prevalence of OIS increased markedly over the studied period which presumably reflects an increasing prevalence of nr-axSpA as the effect of the introduction of ASAS classification criteria for axSpA.

Identifiants

pubmed: 31802208
doi: 10.1007/s00296-019-04482-7
pii: 10.1007/s00296-019-04482-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-330

Références

Ann Rheum Dis. 2009 Jun;68 Suppl 2:ii1-44
pubmed: 19433414
Rheumatol Int. 2015 Aug;35(8):1361-7
pubmed: 25773659
Arthritis Rheum. 1984 Apr;27(4):361-8
pubmed: 6231933
Arthritis Rheum. 2007 May 15;57(4):648-55
pubmed: 17471541
J Rheumatol. 2014 Dec;41(12):2409-12
pubmed: 25362657
Arthritis Rheum. 2008 Mar 15;59(3):449-54
pubmed: 18311755
Clin Rheumatol. 2011 Aug;30(8):1075-80
pubmed: 21360100
Curr Rheumatol Rep. 2018 May 12;20(6):35
pubmed: 29754330
Curr Opin Rheumatol. 1998 Jul;10(4):279-81
pubmed: 9725087
Curr Rheumatol Rep. 2013 Sep;15(9):351
pubmed: 23888360
Arthritis Rheumatol. 2018 Jul;70(7):981-983
pubmed: 29471586
Autoimmun Rev. 2009 Mar;8(5):420-5
pubmed: 19185064
Am J Med Sci. 2013 Jun;345(6):431-6
pubmed: 23841117
Arthritis Rheum. 2011 Nov;63(11):3294-304
pubmed: 21834064
Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii8-18
pubmed: 12381506
Rheumatology (Oxford). 2014 Apr;53(4):650-7
pubmed: 24324212
BMJ Open. 2014 Dec 15;4(12):e006634
pubmed: 25510888

Auteurs

Małgorzata Tłustochowicz (M)

Department of Internal Diseases and Rheumatology, Military Institute of Medicine, ul. Szaserów 128, 04-141, Warszawa, Poland. m.tlustochowicz@gmail.com.

Melania Brzozowska (M)

Department of Management and Logistics in Health Care, Medical University in Lodz, Łódź, Poland.
Department of Drug Management, National Health Fund, Warszawa, Poland.

Waldemar Wierzba (W)

Satellite Campus in Warsaw, University of Humanities and Economics in Lodz, Łódź, Poland.

Filip Raciborski (F)

Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warszawa, Poland.

Brygida Kwiatkowska (B)

Early Arthritis Clinic, National Institute of Geriatrics, Rheumatology and Rehabilitation, ul. Spartańska 1, 02-637, Warszawa, Poland.

Witold Tłustochowicz (W)

Department of Internal Diseases and Rheumatology, Military Institute of Medicine, ul. Szaserów 128, 04-141, Warszawa, Poland.

Andrzej Jacyna (A)

National Health Fund, Warszawa, Poland.

Michał Marczak (M)

Department of Management and Logistics in Health Care, Medical University in Lodz, Łódź, Poland.

Bartłomiej Kisiel (B)

Department of Internal Diseases and Rheumatology, Military Institute of Medicine, ul. Szaserów 128, 04-141, Warszawa, Poland.

Andrzej Śliwczyński (A)

Satellite Campus in Warsaw, University of Humanities and Economics in Lodz, Łódź, Poland.
Department of Healthcare Services, National Health Fund, Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH